PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Jan-2020 AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference AbbVie
03-Jan-2020 Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK Conference  SMi Group
02-Jan-2020 Avantor® to Participate in the J.P. Morgan Healthcare Conference Avantor and Financial News
02-Jan-2020 EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES Evotec SE
02-Jan-2020 GSK completes divestment of rabies and tick-borne encephalitis vaccines to Bavarian Nordic GSK
02-Jan-2020 Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features) Expedeon AG
02-Jan-2020 CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs CF PharmTech, Inc.
31-Dec-2019 111 Named "National High-tech Enterprise" by the Government 111, Inc.
31-Dec-2019 MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc. MagForce AG
31-Dec-2019 MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc. MagForce AG
30-Dec-2019 MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA (news with additional features) MorphoSys AG
30-Dec-2019 PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE HANA PHARM IN SOUTH KOREA PAION AG
30-Dec-2019 PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE HANA PHARM IN SOUTH KOREA PAION AG
27-Dec-2019 First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL (news with additional features) MorphoSys AG
27-Dec-2019 Pivotal Phase 3 Study of DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia Disorder Published in JAMA Network Open Eisai Inc.
27-Dec-2019 BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt BTL
27-Dec-2019 New Major Order From China Bactiguard Holding AB (publ)
27-Dec-2019 Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement Zur Rose Group AG
27-Dec-2019 Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc. Astellas
26-Dec-2019 OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999 OBI Pharma, Inc.